GE HealthCare Technologies (GEHC) announced the launch of a secondary underwritten public offering of 13M shares of its common stock. GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the offering or from the debt-for-equity exchange. Prior to the closing of the offering, General Electric (GE) is expected to exchange the GEHC Shares for indebtedness of GE held by Morgan Stanley Bank, an affiliate of Morgan Stanley & Co., the selling stockholder in the offering by designation of the MS Lender. Following the debt-for-equity exchange, if consummated, Morgan Stanley & Co., as the selling stockholder in the offering, intends to sell the GEHC shares to the underwriter in the offering. The selling stockholder in the offering has granted the underwriter an option to purchase additional shares of GE HealthCare common stock for settlement on or before March 28. Morgan Stanley is acting as the sole book-running manager for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on GEHC:
- GE HealthCare, Biofourmis collaborate to extend patient monitoring
- GE HealthCare Launches Multi-Million Share Offering
- GE HealthCare 13M share Spot Secondary priced at $82.25
- GE HealthCare 13M share Spot Secondary; price range $81.50-$85.63
- GE HealthCare files to sell 13M shares of common stock for holders